The National Center for Advancing Translational Sciences (NCATS) recently highlighted AnaBios’ novel screening platform as part of its social media campaign to share success stories from recipients of Small Business Innovation Research (SBIR) grants. Last year, AnaBios was awarded a SBIR grant to help develop its unique human dorsal root ganglia platform for pre-clinical drug discovery. Click to view the Twitter and LinkedIn posts.